Skip to main content

Advertisement

Log in

Transforming growth factor-β1 inhibits β2-adrenoceptor gene transcription

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract.

Transforming growth factor-β1 (TGF-β1) has been shown to modulate β-adrenoceptor number and function in cultured human tracheal smooth muscle cells and cardiac fibroblasts, but the mechanism is unclear. In this study, we have characterized the β2-adrenoceptor expression by radioligand binding assay, Northern blot analysis and measurement of intracellular cAMP accumulation in a human embryonic lung fibroblast cell line (HEL299 cells). Treatment with TGF-β1 caused a time-dependent decrease in β2-adrenoceptor mRNA, and in receptor number after 24 h. Furthermore, nuclear run-on assays showed a 35% reduction in the transcription rate of the β2-adrenoceptor gene with no alteration in stability of the β2-adrenoceptor mRNA. After TGF-β1 treatment, the basal, procaterol- and forskolin-stimulated cAMP accumulations were also decreased. Cycloheximide inhibited TGF-β1-mediated reduction of β2-adrenoceptor mRNA and protein, whilst alone caused induction of β2-adrenoceptor mRNA without any effect on receptor number. In summary, TGF-β1 induces β2-adrenoceptor desensitization through the alteration in adenylyl cyclase activity and down-regulation of β2-adrenoceptor mRNA and protein through the reduction in the rate of β2-adrenoceptor gene transcription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mak, J., Rousell, J., Haddad, EB. et al. Transforming growth factor-β1 inhibits β2-adrenoceptor gene transcription. Naunyn-Schmied Arch Pharmacol 362, 520–525 (2000). https://doi.org/10.1007/s002100000321

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002100000321

Navigation